Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Inari Medical Inc NARI

Healthcare Medical Devices
Inari Medical, Inc. is a medical device company. The Company’s products primarily consist of ClotTriever and FlowTriever systems, which are catheter-based mechanical thrombectomy systems that are used for the treatment of the venous thromboembolism (VTE) deep vein thrombosis (DVT), and pulmonary embolism (PE). Its InThrill system is used for the removal of emboli and thrombi from the peripheral... see more

Recent & Breaking News (NDAQ:NARI)

Inari Medical to Announce First Quarter 2022 Financial Results

GlobeNewswire April 20, 2022

Inari Medical Announces Closing of Underwriters' Over-Allotment Option in Connection with Offering of Common Stock

GlobeNewswire March 21, 2022

Inari Medical Announces Pricing of Offering of Common Stock

GlobeNewswire March 10, 2022

Inari Medical Announces Proposed Offering of Common Stock

GlobeNewswire March 10, 2022

Inari Medical Appoints Robert Warner to Board of Directors

GlobeNewswire March 1, 2022

Inari Medical Reports Fourth Quarter and Full Year 2021 Financial Results

GlobeNewswire February 23, 2022

Inari Medical Announces First Patient Enrolled in the PEERLESS Trial, a Randomized Controlled Trial Evaluating Outcomes of the FlowTriever® System in Pulmonary Embolism Patients

GlobeNewswire February 15, 2022

Inari Medical to Announce Fourth Quarter and Full-Year 2021 Financial Results

GlobeNewswire February 10, 2022

Inari Medical to Present at Upcoming Investor Conferences

GlobeNewswire February 1, 2022

Inari Medical Reports Preliminary Fourth Quarter 2021 Revenue

GlobeNewswire January 10, 2022

Inari Medical to Present at the 40th Annual J.P. Morgan Healthcare Conference

GlobeNewswire December 29, 2021

Inari Medical Reports Third Quarter 2021 Financial Results

GlobeNewswire November 9, 2021

Inari Medical Announces 6-month FLASH Registry Interim Data Demonstrating Benefits of Lytic-Free Mechanical Thrombectomy in 500 Real-World PE Patients

GlobeNewswire October 28, 2021

Inari Medical to Announce Third Quarter 2021 Financial Results

GlobeNewswire October 26, 2021

Inari Medical Announces Randomized Controlled Trial Evaluating Clinical Outcomes of the FlowTriever® System in Pulmonary Embolism Patients

GlobeNewswire October 18, 2021

Inari Medical Appoints Dana G. Mead, Jr. to Board of Directors

GlobeNewswire October 1, 2021

Inari Medical Appoints Pulmonologist Dr. Victor F. Tapson as VP of Medical Affairs

GlobeNewswire September 21, 2021

Inari Medical to Present at Upcoming Investor Conferences

GlobeNewswire August 26, 2021

Inari Medical Reports Second Quarter 2021 Financial Results 

GlobeNewswire August 10, 2021

Inari Medical to Present at the Canaccord Genuity 41st Annual Growth Conference

GlobeNewswire July 29, 2021